Love him or hate him, President Trump just made the most significant federal cannabis announcement in U.S. history — and for hemp, this is a big deal.

For the first time ever, the White House has formally recognized the medical relevance of cannabinoids, moved marijuana out of Schedule I, and — critically for our industry — explicitly included hemp-derived cannabinoids, including THC, in federal research and regulatory discussion.

This is exactly the kind of acknowledgment hemp has needed.

What the White House Actually Said

In the official Executive Order titled “Increasing Medical Marijuana and Cannabidiol Research,” the administration stated:

“In addition to medical marijuana, which is primarily made up of two cannabinoids — cannabidiol (CBD) and tetrahydrocannabinol (THC) — hemp-derived cannabinoid products, defined by section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o), have shown potential to improve patient symptoms for common ailments and are frequently used by Americans. One in five United States adults and nearly 15 percent of seniors reported using CBD in the past year, and chronic pain patients have reported improvements with CBD use in clinical studies.

Furthermore, evidence suggests that the amount of THC in hemp-derived cannabinoid products can affect both pain treatment efficacy and adverse events.”

This language matters — a lot.

For the first time, the federal government is openly acknowledging that:

• Hemp-derived cannabinoid products are widely used by Americans
• They may provide real symptom relief
• THC levels in hemp products affect both effectiveness and side effects
• These products deserve research and thoughtful regulation — not blanket bans

Why This Is a Huge Win for Hemp

This Executive Order does not change hemp law overnight — but it does something just as important:

✔️ It confirms hemp-derived cannabinoids have medical relevance

✔️ It supports science-based regulation, not prohibition

✔️ It puts hemp-derived THC into the federal research conversation

✔️ It strengthens the case to keep hemp legal

At a time when Congress is debating the future of hemp, this sends a clear message:

Hemp is not a loophole — it is a legitimate industry that deserves clear, sensible rules.

What This Means for Customers

• Hemp remains federally legal
• Nothing changes immediately about availability
• Expect smarter conversations around labeling, dosage, and safety
• Responsible, adult-only hemp products are on the right side of history

At Modern Apotheca, we’ve always believed in:

• Transparency
• Compliance
• Education
• Responsible access

This Executive Order reinforces exactly that approach.

The Bottom Line

This is a major step forward for hemp, science, and common-sense policy.

The White House has now officially recognized what hemp advocates and customers have known for years:

• Hemp-derived cannabinoids matter
• THC levels matter
• Science matters

And that’s exactly how we Keep Hemp Legal.

A significant federal development is underway that could determine the future of hemp-derived cannabinoid products nationwide. Senators Ron Wyden and Jeff Merkley have introduced the Cannabinoid Safety and Regulation Act, a bill that would replace the looming 2026 hemp ban with a national regulatory system.

Instead of eliminating the industry, this bill creates a structured, federally managed pathway for hemp-derived products to remain legal across the United States.

What the Senate Bill Would Require

The bill establishes federal safety standards and potency limits that all hemp-derived consumer products must meet. 

Below are the specific caps included in the legislation:

1. Serving Size THC Limits

• Maximum of 5 milligrams of THC per serving
  (This applies to any intoxicating cannabinoid, including delta-9, delta-8, and others.)

2. Total Container THC Limits

Different product categories have different total THC caps:

• Edibles (gummies, chocolates, baked goods):
  Up to 50 milligrams of THC per package
  (10 standard servings at 5 mg each)
• Beverages:
  Up to 10 servings per container, with 5 mg THC per serving, for a maximum of 50 milligrams THC per bottle or can
• Tinctures:
  Up to 50 milligrams THC per container with a maximum of 5 mg THC per serving
• Vape products:
  Up to 5 milligrams THC per metered dose, with a maximum of 50 milligrams THC per cartridge

3. Additional Federal Requirements

• Mandatory FDA oversight
• Standardized testing and lab certification
• Uniform cannabinoid labeling requirements
• Restrictions on marketing to minors
• Minimum purchase age of 21 and older

States would be free to implement stricter rules but could not ban federally compliant hemp products outright.

Why This Bill Matters

The federal ban passed earlier this year would outlaw the vast majority of hemp-derived cannabinoid products in 2026. Without a legislative fix, thousands of businesses across the country would be forced to close, and millions of adults would lose access to the products they currently rely on.

While the new bill introduces more restrictive potency limits than many markets currently operate under, it ensures the following:

• Hemp-derived products remain federally legal
• The industry continues to operate under a clear national framework
• Farmers, manufacturers, and retailers retain a viable economic pathway
• Adult consumers maintain legal access to regulated cannabinoid products
• Avoidance of a fragmented patchwork of bans, conflicting state rules, and unsafe unregulated alternatives

This bill does not expand the industry; it preserves it. It prevents total federal prohibition and replaces it with a regulated, standardized system.

What Comes Next

Congress will consider this bill in the coming months. Support from consumers, businesses, and state-level stakeholders will be crucial to ensuring the United States adopts regulation rather than prohibition.

To contact your representatives and voice support for regulated, legal hemp, visit KeepHempLegal.com.

A regulated future is possible—but only if action is taken now.